Vivos Therapeutics: Non-Surgical Sleep Apnea Treatment Alternative to CPAP

The Scope of Obstructive Sleep Apnea (OSA)

• 🌎 Obstructive Sleep Apnea (OSA) is a global problem affecting an estimated 1 billion people worldwide.
• 🇺🇸 In the United States, approximately 80 million adults and 10 million children suffer from this disorder, approaching 100 million individuals.
• ⚠️ OSA is often the "tip of the iceberg," linked to numerous other health issues, including bruxism (teeth grinding).

Comorbidities and Holistic Health Impact

• 📈 Over 40 comorbidities have been linked to OSA in the last 60 years, including diabetes, cardiovascular disease, hypertension, Alzheimer's disease, and dementia.
• 🧠 Addressing OSA holistically impacts mental health, physical health, and hormonal health.
• 🚀 Vivos Therapeutics focuses on improving overall health and wellness by treating the root cause of these interconnected conditions.

Vivos Method: Non-Surgical Airway Remodeling

• 💡 Vivos offers an FDA-cleared oral appliance and an integrated treatment protocol known as the Vivos Method.
• 🛠️ This patented device is the first oral medical device to receive FDA clearance for treating severe OSA in adults and moderate to severe OSA in children.
• 🔬 The treatment non-surgically remodels the human airway, making it larger and less prone to collapse.
• 😮 A visual comparison shows a significant increase in airway size after approximately 10 months of treatment.

Treatment and Patient Outcomes

• ✅ The Vivos treatment is described as a "one-and-done" solution, typically completed within 9–12 months.
• ⚡ Once completed, the treatment is intended to last for life, restoring proper breathing and sleep quality.
• 📉 Many patients experience weight loss during the treatment period.
• 🦷 The Vivos appliance also helps with related issues like TMJ disorders and teeth grinding.

Market Opportunity and Investor Focus

• 📈 Vivos Therapeutics, public since 2020, is shifting focus from a dental industry model to directly addressing patients seeking alternatives to CPAP.
• 🎯 The company is targeting patients searching online for solutions, including those dissatisfied with CPAP machines.
• 💰 Vivos has acquired sleep centers, enabling testing for 3,000 patients monthly and offering a viable alternative to the long-standing CPAP treatment.
• 🌐 For investors, Vivos presents an opportunity in a large and growing market for OSA treatment, with a unique, long-lasting solution. More information is available at vivos.com.